Unmasking mechanisms of symptomatic burden in hypertrophic cardiomyopathy using exercise CMR
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease. Following advances in sudden cardiac death prevention, reducing limiting symptoms has become a key therapeutic goal, as nearly half of patients experience functional impairment. Although left ventricular (LV) outflow tract (LVOT) obst...